GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Change In Other Working Capital

Boundless Bio (Boundless Bio) Change In Other Working Capital : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio Change In Other Working Capital?

Boundless Bio's Change In Other Working Capital for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Boundless Bio's Other Working Capital stayed the same from Sep. 2023 to Dec. 2023 .

Boundless Bio's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-2.55 Mil. It means Boundless Bio's Other Working Capital declined by $2.55 Mil from Dec. 2022 to Dec. 2023 .

Boundless Bio Change In Other Working Capital Historical Data

The historical data trend for Boundless Bio's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio Change In Other Working Capital Chart

Boundless Bio Annual Data
Trend Dec21 Dec22 Dec23
Change In Other Working Capital
-0.46 -1.26 -2.55

Boundless Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Change In Other Working Capital Get a 7-Day Free Trial - - - - -

Boundless Bio Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boundless Bio Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Boundless Bio's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Boundless Bio (Boundless Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Change In Other Working Capital
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://www.boundlessbio.com
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Boundless Bio (Boundless Bio) Headlines

From GuruFocus

Boundless Bio Announces Pricing of Initial Public Offering

By Business Wire • 03-27-2024